1. This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More.
Dismiss Notice
Share it!! Hit that Like Button! Tweet It!!

2007-2008 Toyota Yaris Scion Xb Front Passenger Air Bag Recall H0A

Discussion in 'Recalls' started by Lewis, Feb 23, 2017.

  1. Lewis

    Lewis Moderator Staff Member

    Subject: Safety Recall H0A Remedy
    Takata Front Passenger Airbag Inflator (Zone C)

    On May 4, 2016, the National Highway Traffic Safety Administration (NHTSA) announced an expansion of the Takata Airbag Inflator Recalls. This announcement explained that Takata will, over time, recall additional specific front airbag inflators manufactured with phase-stabilized ammonium nitrate (PSAN) propellant that does not contain a material called a “desiccant.” This expansion impacts Toyota and multiple other automotive manufacturers using specific Takata frontal airbag inflators.

    On January 9, 2017, Toyota filed a Defect Information Report (DIR) with the National Highway Traffic Safety Administration (NHTSA) identifying the vehicles involved in the second phase of the Takata recall and informing the agency of our intent to conduct a voluntary Safety Recall on the vehicles described below:

    • 2007 – 2008 Yaris Hatchback
    • 2007 – 2008 Yaris Sedan
    • 2008 Scion xB

    The subject vehicles are equipped with front passenger airbag inflators produced by Takata. According to Takata, the propellant in these inflators may degrade after prolonged exposure to high absolute humidity and fluctuating high temperatures. Degraded propellant can cause inflator rupture during airbag deployment. In the event of an inflator rupture, metal fragments could pass through the airbag cushion material, striking the vehicle occupants, and result in serious injury or death.

    Toyota has sufficient parts to begin a phased implementation of the remedy. The remedy, when available, will consist of the replacement of the airbag inflator or the airbag assembly, depending on the vehicle model. Refer to the following table for anticipated remedy launch timing.

Share This Page